JASON WHITE: Open Payments
NPI 1760861397 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 25 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $29 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $326 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: UBRELVY, Kerendia, VYEPTI, REXULTI, Ozempic, The Cologuard Plus Collection Kit, XOLAIR, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
